Events
Webinar: Public health and policy responses to NAFLD/NASH
WebinarsTopics that will be discussed:
The Impact of NAFLD/NASH
What is being done to tackle NAFLD/NASH globally and nationally
What still needs to be done in the fight against NAFLD/NASH
How can you/your country advance the battle against…
Webinar: NAFLD Patient identification strategies
WebinarsProf. Jörn Schattenberg discussed his paper in Nature Reviews Gastroenterology & Hepatology on effective and efficient models of care for patients with NAFLD. Standardized patient care pathways for NAFLD are not yet widely implemented and…
Webinar: Phase 2 Clinical trial results of the Pan-PPAR Agonist Lanifibranor in NASH patients
WebinarsIn this webinar Prof. Sven Francque will be discussing the phase 2 trial results of the Pan-PPAR Agonist Lanifibranor in nonalcoholic steatohepatitis (NASH) patients. Currently there is an unmet need of management of NASH. Lanifibranor is a…
